Protara Therapeutics, Inc. - Common Stock (TARA)

41 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q1 2024.
Protara Therapeutics, Inc. - Common Stock (TARA) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,570,660 shares of 38,466,645 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2,692,594 shares), VANGUARD GROUP INC (427,612 shares), Boxer Capital, LLC (209,227 shares), Ikarian Capital, LLC (202,701 shares), BAKER BROS. ADVISORS LP (199,671 shares), STEMPOINT CAPITAL LP (168,442 shares), Privium Fund Management (UK) Ltd (119,730 shares), RENAISSANCE TECHNOLOGIES LLC (84,600 shares), GEODE CAPITAL MANAGEMENT, LLC (82,907 shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (59,000 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.